Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $2.04 USD
Change Today +0.04 / 2.00%
Volume 3.2K
MBLX On Other Exchanges
Symbol
Exchange
MBLX is not on other exchanges.
As of 1:57 PM 08/31/15 All times are local (Market data is delayed by at least 15 minutes).

metabolix inc (MBLX) Snapshot

Open
$1.96
Previous Close
$2.00
Day High
$2.18
Day Low
$1.96
52 Week High
09/8/14 - $9.06
52 Week Low
08/24/15 - $1.07
Market Cap
55.0M
Average Volume 10 Days
17.3K
EPS TTM
$-1.52
Shares Outstanding
27.0M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for METABOLIX INC (MBLX)

Related News

No related news articles were found.

metabolix inc (MBLX) Related Businessweek News

No Related Businessweek News Found

metabolix inc (MBLX) Details

Metabolix, Inc., an advanced biomaterials company, focuses on delivering sustainable solutions to the plastics industry. The company develops and commercializes technologies for the production of polymers and chemicals in microbes and plants. It produces a family of biopolymers found in nature called polyhydroxyalkanoates (PHA), which occur naturally in living organisms and are chemically similar to polyesters. The company offers biobased polymeric modifiers for rigid, semi-rigid, and flexible polyvinyl chloride compounds, which are used in construction materials and medical applications. It is also developing PHA biopolymers as performance additives, and biobased and marine biodegradable micropowders for functional biodegradation; and PHA barrier coatings for use in paper and cardboard applications. In addition, the company has entered into a commercial and technology alliance with Honeywell International, Inc. for the development of marine biodegradable biopolymers for use in cosmetics and personal care products. The company offers its biopolymers under the Mirel brand. Metabolix, Inc. was founded in 1992 and is based in Cambridge, Massachusetts.

68 Employees
Last Reported Date: 03/25/15
Founded in 1992

metabolix inc (MBLX) Top Compensated Officers

Chief Executive Officer, President and Direct...
Total Annual Compensation: $348.7K
Co-Founder, Chief Scientific Officer and Dire...
Total Annual Compensation: $225.1K
Principal Financial Officer, Chief Accounting...
Total Annual Compensation: $188.4K
Chief Operating Officer
Total Annual Compensation: $295.0K
Vice President of Marketing and Corporate Com...
Total Annual Compensation: $220.0K
Compensation as of Fiscal Year 2014.

metabolix inc (MBLX) Key Developments

Metabolix, Inc. Reports Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended June 30, 2015

Metabolix, Inc. reported unaudited consolidated earnings results for the second quarter and six months ended June 30, 2015. For the quarter, the company reported total revenue of $744,000 compared to $699,000 a year ago. Loss from continuing operations was $6,129,000 or $0.26 diluted per share compared to $6,766,000 or $1.16 diluted per share a year ago. Net loss was $6,073,000 or $0.26 per diluted share compared to $7,235,000 or $1.24 per diluted share a year ago. The company's net cash used in operating activities during the second quarter of 2015 was $5.5 million, which was an increase of $0.6 million from the $4.9 million used for operating activities during the second quarter of 2014. For the six months period, the company reported total revenue of $1,389,000 compared to $1,312,000 a year ago. Loss from continuing operations was $11,959,000 or $0.52 diluted per share compared to $14,263,000 or $2.45 diluted per share a year ago. Net loss was $11,916,000 or $0.52 per diluted share compared to $15,389,000 or $2.65 per basic and diluted share a year ago. Net cash used by continuing operations for operating activities was $12,129,000 compared to $13,846,000 a year ago. Purchase of property and equipment was $209,000 compared to $100,000 a year ago.

Metabolix, Inc. to Report Q2, 2015 Results on Aug 12, 2015

Metabolix, Inc. announced that they will report Q2, 2015 results at 4:30 PM, US Eastern Standard Time on Aug 12, 2015

Metabolix, Inc., Q2 2015 Earnings Call, Aug 12, 2015

Metabolix, Inc., Q2 2015 Earnings Call, Aug 12, 2015

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
MBLX:US $2.04 USD +0.04

MBLX Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Biome Technologies PLC 127.50 GBp 0.00
Corbion NV €19.60 EUR 0.00
Kaneka Corp ¥983.00 JPY -13.00
Showa Denko KK ¥139.00 JPY -6.00
Teijin Ltd ¥386.00 JPY -4.00
View Industry Companies
 

Industry Analysis

MBLX

Industry Average

Valuation MBLX Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 16.1x
Price/Book 2.3x
Price/Cash Flow NM Not Meaningful
TEV/Sales 10.9x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact METABOLIX INC, please visit www.metabolix.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.